Programmed cell death: the pathways to severe COVID-19?
暂无分享,去创建一个
[1] G. Wei,et al. Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance , 2022, J. Chem. Inf. Model..
[2] Rui Wang,et al. Omicron (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance , 2021, ArXiv.
[3] G. Luo,et al. Omicron variant (B.1.1.529) of SARS‐CoV‐2, a global urgent public health alert! , 2021, Journal of medical virology.
[4] Judith L. Strymish,et al. Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study , 2021, PloS one.
[5] A. Krvavac,et al. Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19 , 2021, Frontiers in Immunology.
[6] Haoran Peng,et al. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation , 2021, Cell Research.
[7] M. Campanella,et al. Pyroptosis targeting via mitochondria: An educated guess to innovate COVID‐19 therapies , 2021, British journal of pharmacology.
[8] A. Oberst,et al. ZBP1 induces inflammatory signaling via RIPK3 and promotes SARS-CoV-2-induced cytokine expression , 2021, bioRxiv.
[9] M. Pereira,et al. Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2 , 2021, Reviews in medical virology.
[10] Pramod K. Gupta,et al. Host directed therapies: COVID-19 and beyond , 2021, Current Research in Pharmacology and Drug Discovery.
[11] F. Mami-Chouaib,et al. When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak , 2021, Frontiers in Immunology.
[12] G. Frühbeck,et al. FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes , 2021, Cellular & Molecular Immunology.
[13] I. Zanoni. Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? , 2021, Current Opinion in Virology.
[14] J. Dogné,et al. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments , 2021, Frontiers in Pharmacology.
[15] R. Maehr,et al. SARS-CoV-2 Initiates Programmed Cell Death in Platelets , 2021, Circulation research.
[16] Weitao Li,et al. SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage , 2021, The EMBO journal.
[17] Lei Liu,et al. Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study , 2021, International journal of laboratory hematology.
[18] S. Brohawn,et al. Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs , 2021, Nature Structural & Molecular Biology.
[19] M. Hibberd,et al. A blood RNA transcriptome signature for COVID-19 , 2021, BMC medical genomics.
[20] R. Gainetdinov,et al. Viral infiltration of pancreatic islets in patients with COVID-19 , 2021, Nature Communications.
[21] I. Wicks,et al. BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropenia. , 2021, Blood advances.
[22] Jian-Piao Cai,et al. Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity , 2021, Science Advances.
[23] G. Bowlin,et al. Patients with COVID-19: in the dark-NETs of neutrophils , 2021, Cell Death & Differentiation.
[24] R. Sadreyev,et al. Type I, II, and III interferon signatures correspond to COVID-19 disease severity , 2021, The Journal of infectious diseases.
[25] Steve B Jones,et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial , 2021, Lancet.
[26] J. Schultze,et al. Neutrophils in COVID-19 , 2021, Frontiers in Immunology.
[27] H. Moch,et al. Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patients , 2021, bioRxiv.
[28] L. Bailly,et al. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity , 2021, Blood Advances.
[29] J. Lieberman,et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release , 2021, medRxiv.
[30] M. Mitreva,et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection , 2021, Communications biology.
[31] Carolina Q. Sacramento,et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes , 2021, Cell death discovery.
[32] M. Diamond,et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2021, JACC: Basic to Translational Science.
[33] Jiahuai Han,et al. Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells , 2021, Cell Discovery.
[34] A. Zangrillo,et al. Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies. , 2021, European Journal of Internal Medicine.
[35] J. Casanova,et al. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4 , 2021, The Journal of experimental medicine.
[36] M. Aikawa,et al. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19 , 2021, Frontiers in Cardiovascular Medicine.
[37] H. Moch,et al. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients , 2021, Clinical & translational immunology.
[38] P. McPherson,et al. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis , 2021, Journal of Biological Chemistry.
[39] P. Ball. The lightning-fast quest for COVID vaccines — and what it means for other diseases , 2020, Nature.
[40] D. Knapp,et al. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients , 2020, Cell death discovery.
[41] T. Kohlsdorf,et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients , 2020, The Journal of experimental medicine.
[42] Ayyalusamy Ramamoorthy. Faculty Opinions recommendation of Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[43] R. Webby,et al. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes , 2020, Cell.
[44] M. Diamond,et al. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis , 2020, bioRxiv.
[45] A. Kolocouris,et al. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers , 2020, Nature Structural & Molecular Biology.
[46] Yanjing Li,et al. The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer , 2020, Cell Death Discovery.
[47] A. Abbate,et al. Inflammasome formation in the lungs of patients with fatal COVID-19 , 2020, Inflammation research : official journal of the European Histamine Research Society ... [et al.].
[48] T. Kanneganti,et al. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines , 2020, Trends in Immunology.
[49] Peng Zhou,et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation , 2020, Signal Transduction and Targeted Therapy.
[50] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[51] A. Kolocouris,et al. Structure and Drug Binding of the SARS-CoV-2 Envelope Protein in Phospholipid Bilayers , 2020, Research square.
[52] B. Gärtner,et al. High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19 , 2020, JCI insight.
[53] P. Saldiva,et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology , 2020, The Journal of experimental medicine.
[54] A. Strasser,et al. Emerging connectivity of programmed cell death pathways and its physiological implications , 2020, Nature Reviews Molecular Cell Biology.
[55] Lisa E. Gralinski,et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures , 2020, Nature.
[56] L. Milani,et al. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 , 2020, Scientific Reports.
[57] Keith Sigel,et al. An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.
[58] N. Koulouris,et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison , 2020, Nature Immunology.
[59] J. Mason,et al. A dynamic COVID-19 immune signature includes associations with poor prognosis , 2020, Nature Medicine.
[60] Jiyuan Zhang,et al. Single-cell landscape of immunological responses in patients with COVID-19 , 2020, Nature Immunology.
[61] Soham Saha,et al. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies , 2020, PloS one.
[62] Madeleine K. D. Scott,et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans , 2020, Science.
[63] A. Alam,et al. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past , 2020, Frontiers in Immunology.
[64] M. Mitreva,et al. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection , 2020, Communications Biology.
[65] R. Webby,et al. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection , 2020, The Journal of Biological Chemistry.
[66] T. Kohlsdorf,et al. Inflammasome activation in COVID-19 patients , 2020, medRxiv.
[67] Alexander Sczyrba,et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment , 2020, Cell.
[68] M. Tateyama,et al. Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19 , 2020, Critical Care.
[69] M. Maes,et al. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach , 2020, Life Sciences.
[70] M. Hémadi,et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.
[71] Eric Song,et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.
[72] Y. Marie,et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity , 2020, Nature Cell Biology.
[73] A. Strasser,et al. Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection , 2020, Immunity.
[74] G. Gao,et al. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients , 2020, Immunity.
[75] D. Wagner,et al. Cellular Mechanisms of NETosis. , 2020, Annual review of cell and developmental biology.
[76] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[77] Inkyung Jung,et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 , 2020, Science Immunology.
[78] B. Gärtner,et al. High levels of SARS-CoV-2 specific T-cells with restricted functionality in patients with severe course of COVID-19 , 2020, medRxiv.
[79] T. Ueland,et al. Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19 , 2020, Scientific Reports.
[80] C. Takiya,et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) , 2020, Scientific Reports.
[81] J. O’Donnell,et al. Endothelial cells orchestrate COVID-19 coagulopathy , 2020, The Lancet Haematology.
[82] C. Hunter,et al. Cytokine Storms: Understanding COVID-19 , 2020, Immunity.
[83] C. von Kalle,et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.
[84] A. Velde,et al. Severe COVID-19: NLRP3 Inflammasome Dysregulated , 2020 .
[85] R. Bartenschlager,et al. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells , 2020, Cell reports.
[86] S. Tavakolpour,et al. Lymphopenia during the COVID-19 infection: What it shows and what can be learned , 2020, Immunology Letters.
[87] S. Brohawn,et al. Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs , 2020, bioRxiv.
[88] Fang Lin,et al. Clinical and pathological investigation of patients with severe COVID-19 , 2020, JCI Insight.
[89] Yang Han,et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells , 2020, Cellular & Molecular Immunology.
[90] Yang Han,et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells , 2020, Cellular & Molecular Immunology.
[91] Aaron J. Wilk,et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19 , 2020, Nature Medicine.
[92] J. Thompson,et al. Characterization of accessory genes in coronavirus genomes , 2020, Virology Journal.
[93] Lisa E. Gralinski,et al. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract , 2020, Cell.
[94] R. Pranata,et al. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis , 2020, Journal of Intensive Care.
[95] R. Reiter,et al. Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 , 2020, Life Sciences.
[96] J. Soriano,et al. Differential Redistribution of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-19 , 2020, medRxiv.
[97] I. Amit,et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.
[98] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[99] B. V. Van Tassell,et al. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease , 2020, Circulation research.
[100] S. Zhang,et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig , 2020, Nature Communications.
[101] R. Woods,et al. Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.
[102] R. Bartenschlager,et al. Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells , 2020, bioRxiv.
[103] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[104] M. Netea,et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.
[105] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[106] G. Ippolito,et al. COVID-19, SARS and MERS: are they closely related? , 2020, Clinical Microbiology and Infection.
[107] Hui Guo,et al. Risk-adapted Treatment Strategy For COVID-19 Patients , 2020, International Journal of Infectious Diseases.
[108] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[109] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[110] Z. Tian,et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[111] Yuntao Wu,et al. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.
[112] Yuntao Wu,et al. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools , 2020, Virologica Sinica.
[113] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[114] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[115] Bo Diao,et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.
[116] M. Pasparakis,et al. Z-nucleic acid sensing triggers ZBP1-dependent necroptosis and inflammation , 2020, Nature.
[117] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[118] J. Rocklöv,et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.
[119] P. Niu,et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China , 2020, Cell Host & Microbe.
[120] T. Toda,et al. Mitogen-Activated Protein Kinase , 2020, Definitions.
[121] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[122] Lisa E. Gralinski,et al. Return of the Coronavirus: 2019-nCoV , 2020, Viruses.
[123] D. Normile. Novel human virus? Pneumonia cases linked to seafood market in China stir concern , 2020 .
[124] M. Shi,et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.
[125] Dong-Yan Jin,et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses , 2020, Emerging microbes & infections.
[126] M. Pasparakis,et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis , 2019, Nature.
[127] T. Jin,et al. Pharmacological Inhibitors of the NLRP3 Inflammasome , 2019, Front. Immunol..
[128] G. Homuth,et al. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-inflammatory Response Syndromes in Mice With Acute Pancreatitis. , 2019, Gastroenterology.
[129] S. Anderson,et al. Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and III Interferons. , 2019, Immunity.
[130] C. Shi,et al. SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes , 2019, Cell Death Discovery.
[131] Huanchun Chen,et al. An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS) , 2019, PLoS pathogens.
[132] J. Ting,et al. The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.
[133] Mingzhou Chen,et al. SG formation relies on eIF4GI-G3BP interaction which is targeted by picornavirus stress antagonists , 2019, Cell Discovery.
[134] Chuan Qin,et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.
[135] Jie Cui,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[136] S. Fulda,et al. Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells1 , 2018, Neoplasia.
[137] D. Green,et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection , 2018, Proceedings of the National Academy of Sciences.
[138] J. Bertin,et al. Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.
[139] Junying Yuan,et al. TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging , 2018, Cell.
[140] Xun Xiao,et al. SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death , 2018, Cell Death & Disease.
[141] Min Wang,et al. SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death , 2018, Cell Death & Disease.
[142] R. Krüger,et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps , 2018, Science Immunology.
[143] M. Sorokin,et al. Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis , 2018, Cell Death & Differentiation.
[144] J. Klco,et al. TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation , 2018, The Journal of experimental medicine.
[145] G. Neale,et al. IRF1 Is a Transcriptional Regulator of ZBP1 Promoting NLRP3 Inflammasome Activation and Cell Death during Influenza Virus Infection , 2018, The Journal of Immunology.
[146] Xiaoliang Yu,et al. GSDME as an executioner of chemotherapy-induced cell death , 2017, Science China Life Sciences.
[147] V. Papayannopoulos. Neutrophil extracellular traps in immunity and disease , 2017, Nature Reviews Immunology.
[148] M. Cho,et al. Interferon-gamma regulates inflammatory cell death by targeting necroptosis in experimental autoimmune arthritis , 2017, Scientific Reports.
[149] F. Swirski,et al. Cytokine storm and sepsis disease pathogenesis , 2017, Seminars in Immunopathology.
[150] D. Green,et al. Caspase‐8: regulating life and death , 2017, Immunological reviews.
[151] A. Oberst,et al. MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D , 2017, The Journal of Immunology.
[152] D. Vaux,et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner , 2017, Proceedings of the National Academy of Sciences.
[153] E. Alnemri,et al. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death , 2017, Nature Communications.
[154] D. Averill-Bates,et al. Activation of apoptosis signalling pathways by reactive oxygen species. , 2016, Biochimica et biophysica acta.
[155] G. Núñez,et al. Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.
[156] M. Pasparakis,et al. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation , 2016, Nature.
[157] Si Ming Man,et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways , 2016, Science Immunology.
[158] M. Lamkanfi,et al. Pyroptosis , 2016, Current Biology.
[159] K. Elkon,et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease , 2015, Nature Medicine.
[160] Z. Liu,et al. Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate , 2015, Cell Death and Disease.
[161] Haitao Guo,et al. Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.
[162] O. Eickelberg,et al. Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction , 2015, Mediators of inflammation.
[163] J. Bertin,et al. A RIPK3–Caspase 8 Complex Mediates Atypical Pro–IL-1β Processing , 2015, The Journal of Immunology.
[164] Si Ming Man,et al. The transcription factor IRF1 and guanylate-binding proteins target AIM2 inflammasome activation by Francisella infection , 2015, Nature Immunology.
[165] A. Sher,et al. Type I interferons in infectious disease , 2015, Nature Reviews Immunology.
[166] P. Vandenabeele,et al. Necroptosis and its role in inflammation , 2015, Nature.
[167] E. Victor,et al. Interferon-gamma induced cell death: Regulation and contributions of nitric oxide, cJun N-terminal kinase, reactive oxygen species and peroxynitrite. , 2014, Biochimica et biophysica acta.
[168] S. Chi,et al. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313 , 2014, Proceedings of the National Academy of Sciences.
[169] W. Alexander,et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death , 2014, Proceedings of the National Academy of Sciences.
[170] J. Horng,et al. ER stress, autophagy, and RNA viruses , 2014, Front. Microbiol..
[171] N. Rothwell,et al. Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death* , 2014, The Journal of Biological Chemistry.
[172] C. Rice,et al. Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.
[173] Toru Okamoto,et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. , 2013, Immunity.
[174] T. Kanneganti,et al. Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection , 2013, Front. Cell. Infect. Microbiol..
[175] J. Bertin,et al. Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL* , 2013, The Journal of Biological Chemistry.
[176] A. Degterev,et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases , 2013, Proceedings of the National Academy of Sciences.
[177] C. Carmona-Rivera,et al. Neutrophil Extracellular Trap–Associated Protein Activation of the NLRP3 Inflammasome Is Enhanced in Lupus Macrophages , 2013, The Journal of Immunology.
[178] Michael G. Katze,et al. Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.
[179] A. Tardivel,et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway , 2012, Cell Death and Disease.
[180] Yuqiong Liang,et al. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3–mediated pathway , 2011, Proceedings of the National Academy of Sciences.
[181] V. Dixit,et al. Manipulation of host cell death pathways during microbial infections. , 2010, Cell host & microbe.
[182] C. Gabay,et al. IL-1 pathways in inflammation and human diseases , 2010, Nature Reviews Rheumatology.
[183] D. Cleri,et al. Severe Acute Respiratory Syndrome (SARS) , 2010, Infectious Disease Clinics of North America.
[184] S. Aaronson,et al. Dual Role of p53 in Innate Antiviral Immunity , 2010, Viruses.
[185] S. Mohr,et al. P2X7 Receptor-Stimulated Secretion of MHC Class II-Containing Exosomes Requires the ASC/NLRP3 Inflammasome but Is Independent of Caspase-1 1 , 2009, The Journal of Immunology.
[186] G. Whittaker,et al. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.
[187] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[188] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[189] D. Andrews,et al. Bid: a Bax-like BH3 protein , 2008, Oncogene.
[190] S. Janssens,et al. Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1  Maturation by Caspase-8 , 2022 .
[191] Z. Ye,et al. A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis , 2008, Biochimica et Biophysica Acta (BBA) - General Subjects.
[192] S. Inoue,et al. Clathrin-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus into Target Cells Expressing ACE2 with the Cytoplasmic Tail Deleted , 2007, Journal of Virology.
[193] Ralph Baric,et al. A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.
[194] B. He. Viruses, endoplasmic reticulum stress, and interferon responses , 2006, Cell Death and Differentiation.
[195] P. Palese,et al. 7a Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cellular Protein Synthesis and Activates p38 Mitogen-Activated Protein Kinase , 2006, Journal of Virology.
[196] S. Gollapudi,et al. Role of NF-κB signaling pathway in increased tumor necrosis factor-α-induced apoptosis of lymphocytes in aged humans , 2005, Cell Death and Differentiation.
[197] J. Xie,et al. Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome , 2004, The Journal of infectious diseases.
[198] B. Williams,et al. Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis , 2003, Apoptosis.
[199] J. Steinke,et al. 2. Cytokines and chemokines. , 2003, The Journal of allergy and clinical immunology.
[200] J. Cruse,et al. 10 - Cytokines and Chemokines , 2004 .
[201] M. Hengartner. The biochemistry of apoptosis , 2000, Nature.
[202] G. Barber. The interferons and cell death: guardians of the cell or accomplices of apoptosis? , 2000, Seminars in cancer biology.
[203] K. Elkon. Caspases , 1999, The Journal of Experimental Medicine.
[204] S. Aggarwal,et al. Increased TNF-α-Induced Apoptosis in Lymphocytes from Aged Humans: Changes in TNF-α Receptor Expression and Activation of Caspases , 1999, The Journal of Immunology.
[205] G. Salvesen,et al. Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.
[206] G. Kaplan,et al. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.
[207] Type I , II , and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity , 2021 .
[208] W. Lim,et al. Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .
[209] L. Milani,et al. Longitudinal proteomic pro ling reveals increased early in ammation and sustained apoptosis proteins in severe COVID-19 , 2020 .
[210] Qin Ning,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .
[211] J. Reina,et al. [The Middle East respiratory syndrome coronavirus]. , 2015, Medicina clinica.
[212] Z. Ye,et al. The role of SARS-CoV protein, ORF-6, in the induction of host cell death. , 2010, Hong Kong medical journal = Xianggang yi xue za zhi.
[213] S. Ryter,et al. Mechanisms of cell death in oxidative stress. , 2007, Antioxidants & redox signaling.